Keynote Speakers
Steven C. George Professor and Chair, University of California, Davis | 
Linda Griffith Professor, Massachusetts Institute of Technology (MIT) | 
Peter Ertl Professor of Lab-on-a-Chip Systems, Vienna University of Technology | 
Kevin Healy Jan Fandrianto and Selfia Halim Distinguished Professorship in Engineering, University of California, Berkeley | 
Michael Shuler Samuel B. Eckert Professor of Engineering, Cornell University, President & CEO, Hesperos, Inc. | 
Nancy Allbritton Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering, University of Washington in Seattle |
|

John Wikswo Gordon A. Cain University Professor, A.B. Learned Professor of Living State Physics; Founding Director, Vanderbilt Institute for Integrative Biosystems, Vanderbilt University | 
Danilo Tagle Associate Director For Special Initiatives, Office of the Director, National Center for Advancing Translational Sciences at the NIH (NCATS) | 
Roger Kamm Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT) |
OverviewSelectBIO 8th Annual 3D-Culture, Organoids and Organs-on-Chips 2021
Conference will be held on-site in-person on Coronado Island, California. The Conferences focuses on an important and expanding field wherein cells are being
assembled using Microfluidics and Lab-on-a-Chip technologies in a
functionally-relevant manner. These clusters of "assembled cells" have
functional significance and can mimic in vivo organ structure.
Liver
cells assembled on-board chips in a physiologically-relevant
architecture using microfluidics can, for instance, be utilized for
toxicity screening and the ability to assemble organ fragments ex vivo
can provide an exquisite means to reconstruct biological processes
(both physiological and pathological) "in a dish" or "on a chip." A
number of chips such Lung-on-a-Chip, Brain-on-a-Chip, Gut-on-a-Chip,
Marrow-on-a-Chip, Bone-on-a-Chip, Nerve-on-a-Chip amongst others have
been built and will be presented and explored at this conference. We
will also focus on "disease-on-a-chip", cancer-on-a-chip, immune
system-on-a-chip.
The Conference Tracks are Co-Located and Concurrent and
Delegates can
Participate, Mix-and-Match Presentations and Network Extensively with
their Colleagues from all Co-Located and Concurrent Conference Tracks.
There is a co-located concurrently-running on-site exhibition bringing companies together from around the world. An excellent opportunity for companies to network and engage offering opportunities for sales and business development networking.
Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event. Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event.
Call for PapersIf you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now! Oral Presentation Submission Deadline: 30 September 2021 Call for PostersYou can also present your research on a poster while attending the meeting. Submit an abstract for consideration now! Poster Submission Deadline: 06 December 2021 Agenda Topics- Artery-on-a-Chip for Cardiovascular Disease Research
- Bone-on-a-chip
- Cancer-on-a-Chip
- Disease-on-a-Chip
- Gut-on-a-Chip
- Liver-on-a-Chip for Toxicity Screening/Toxicology Studies
- Lung-on-a-Chip
- Organ-on-a-Chip Applications for Drug Discovery and Toxicity Screening
- Organ-on-a-Chip/Body-on-a-Chip Assembly using Microfluidics: Tools and Approaches
- Organoids-on-a-Chip
- Spheroids -- 3D Aggregates of Cells in Culture: Technologies and Applications
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateGary Gintant, Senior Research Fellow, Abbvie James Hickman, Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos Ali Khademhosseini, CEO, Terasaki Institute for Biomedical Innovation Shay Soker, Professor of Regenerative Medicine and Chief Science Program Officer, Wake Forest Institute for Regenerative Medicine
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|